SKYRIZI
SKYRIZI (risankizumab-rzaa) is an intravenous prescription medicine used for the treatment of moderately to severely active Crohn’s disease.
For more information, visit the patient website for this drug. Speak with your healthcare provider to learn if this drug is right for you.
What it treats
Crohn’s Disease
Prescribed by
Various medical specialists
How it’s administered
Intravenous (IV) infusion
Frequency
Week zero, week four, then every
12 weeks thereafter
Length of treatment
About one hour